News
Regulatory affairsRegulatory Round-up - December 2025
Cell and Gene Therapy Catapult launches new network for the advanced therapies industry in ScotlandRegulatory Round-up - August 2023Cell and Gene Therapy Catapult, Rentschler Biopharma and Refeyn collaborate to improve process analytical technologies and AAV manufacturing for gene therapiesCell and Gene Therapy Catapult to support FourPlus in testing its immersive technology training platformPlasticell, Cell and Gene Therapy Catapult and Imperial College London obtain funding to develop manufacturing platform for allogeneic cell immunotherapiesRegulatory Round-up - July 2023Cell and Gene Therapy Catapult appoints Jeanette Evans as Chief Business OfficerCell and Gene Therapy Catapult to support the development of NK:IO’s natural killer cell therapyThe Advanced Therapies Apprenticeship Community welcomes its 300th apprenticeRegulatory Round-up - June 2023Autolomous and the Cell and Gene Therapy Catapult awarded £1.2m grant by UK Research and InnovationCell and Gene Therapy Catapult opens new laboratories and offices in Edinburgh BioQuarter